| Abstrakt: |
A recent study conducted by researchers in Cairo, Egypt has explored the potential therapeutic effects of echinochrome (Ech) on phenylhydrazine (PHZ)-induced hemolytic anemia (HA) in rats. The study found that Ech supplementation resulted in significant improvements in various blood parameters, antioxidant levels, and liver and kidney health in anemic rats. The researchers concluded that Ech has anti-inflammatory and antioxidant properties that contribute to its hepatorenal protective effect. This research provides valuable insights into potential treatments for HA and highlights the potential benefits of Ech in managing this condition. [Extracted from the article] |
